These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 7547982

  • 1. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
    Kaspárková J, Brabec V.
    Biochemistry; 1995 Sep 26; 34(38):12379-87. PubMed ID: 7547982
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.
    Donahue BA, Augot M, Bellon SF, Treiber DK, Toney JH, Lippard SJ, Essigmann JM.
    Biochemistry; 1990 Jun 19; 29(24):5872-80. PubMed ID: 2383564
    [Abstract] [Full Text] [Related]

  • 3. Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.
    Leng M, Locker D, Giraud-Panis MJ, Schwartz A, Intini FP, Natile G, Pisano C, Boccarelli A, Giordano D, Coluccia M.
    Mol Pharmacol; 2000 Dec 19; 58(6):1525-35. PubMed ID: 11093793
    [Abstract] [Full Text] [Related]

  • 4. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J, Marini V, Najajreh Y, Gibson D, Brabec V.
    Biochemistry; 2003 May 27; 42(20):6321-32. PubMed ID: 12755637
    [Abstract] [Full Text] [Related]

  • 5. Superhelical torsion controls DNA interstrand cross-linking by antitumor cis- diamminedichloroplatinum(II).
    Vrána O, Boudný V, Brabec V.
    Nucleic Acids Res; 1996 Oct 15; 24(20):3918-25. PubMed ID: 8918792
    [Abstract] [Full Text] [Related]

  • 6. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
    Kaspárková J, Nováková O, Vrána O, Farrell N, Brabec V.
    Biochemistry; 1999 Aug 24; 38(34):10997-1005. PubMed ID: 10460154
    [Abstract] [Full Text] [Related]

  • 7. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ.
    Nature; 1999 Jun 17; 399(6737):708-12. PubMed ID: 10385126
    [Abstract] [Full Text] [Related]

  • 8. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
    Hofr C, Farrell N, Brabec V.
    Nucleic Acids Res; 2001 May 15; 29(10):2034-40. PubMed ID: 11353072
    [Abstract] [Full Text] [Related]

  • 9. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J, Novakova O, Farrell N, Brabec V.
    Biochemistry; 2003 Jan 28; 42(3):792-800. PubMed ID: 12534292
    [Abstract] [Full Text] [Related]

  • 10. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.
    Cohen SM, Mikata Y, He Q, Lippard SJ.
    Biochemistry; 2000 Sep 26; 39(38):11771-6. PubMed ID: 10995245
    [Abstract] [Full Text] [Related]

  • 11. Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.
    Pérez C, Leng M, Malinge JM.
    Nucleic Acids Res; 1997 Feb 15; 25(4):896-903. PubMed ID: 9016644
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.
    Kasparkova J, Farrell N, Brabec V.
    J Biol Chem; 2000 May 26; 275(21):15789-98. PubMed ID: 10747955
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin.
    Chválová K, Brabec V, Kaspárková J.
    Nucleic Acids Res; 2007 May 26; 35(6):1812-21. PubMed ID: 17329374
    [Abstract] [Full Text] [Related]

  • 17. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.
    Pilch DS, Dunham SU, Jamieson ER, Lippard SJ, Breslauer KJ.
    J Mol Biol; 2000 Feb 25; 296(3):803-12. PubMed ID: 10677282
    [Abstract] [Full Text] [Related]

  • 18. Transplatin-modified oligonucleotides as modulators of gene expression.
    Giraud-Panis M, Leng M.
    Pharmacol Ther; 2000 Mar 25; 85(3):175-81. PubMed ID: 10739872
    [Abstract] [Full Text] [Related]

  • 19. DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].
    Zákovská A, Nováková O, Balcarová Z, Bierbach U, Farrell N, Brabec V.
    Eur J Biochem; 1998 Jun 15; 254(3):547-57. PubMed ID: 9688265
    [Abstract] [Full Text] [Related]

  • 20. Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
    Kasparkova J, Novakova O, Marini V, Najajreh Y, Gibson D, Perez JM, Brabec V.
    J Biol Chem; 2003 Nov 28; 278(48):47516-25. PubMed ID: 12970368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.